Gliclazide Tablet: Uses, Dosage & Side Effects in Pakistan

Gliclazide Tablet Uses, Dosage, Side Effects & Price in Pakistan

1. Quick Info (Mukhtasir Maloomat)

2. What is Gliclazide Tablet? (Gliclazide Tablet kya hai)

Gliclazide Tablet, brand name Diamicron, is a Sulfonylurea anti-diabetic medicine. It closes ATP-sensitive potassium (K+) channels on pancreatic beta cells, causing them to depolarise and release insulin. The result: blood sugar (glucose) decreases.

In Pakistan, Diamicron is commonly prescribed for Type 2 Diabetes Mellitus. It is an Rx medicine — only take it on a doctor's instructions.

IMPORTANT: The biggest risk is HYPOGLYCAEMIA (low blood sugar). Make sure to remember its symptoms and emergency action.

3. Uses (Fayde / Kis kaam aati hai)

• Type 2 Diabetes Mellitus

4. Who May Use It (Kis ko leni chahiye)

A healthcare professional should confirm that the indication, age and exact formulation match the patient’s needs. An ingredient match alone does not make another brand or formulation interchangeable.

5. When Not to Use (Kab nahi leni chahiye)

• Low blood sugar can cause sweating, shaking or confusion. If awake and able to swallow, follow the advised fast-acting carbohydrate treatment.
• If unconscious, fitting or unable to swallow, do not give food or drink; call emergency services.
• Risk of prolonged low blood sugar is higher with missed meals and kidney or liver disease.
• A clinician should plan treatment before Ramadan fasting.
• Beta-blockers can mask some low-blood-sugar symptoms.

6. Dosage (Kitni leni hai)

Adult guidance

The dose depends on whether the tablet is standard-release (such as 80 mg) or modified-release (30 mg or 60 mg). Follow the exact formulation’s prescription; do not exchange strengths tablet-for-tablet.

Child guidance

Not recommended in children — adult-onset Type 2 diabetes medicine

Dose limits

Use the limit specified for your exact product and individual prescription. A strength printed on a pack is not automatically a recommended dose.

7. How to Use (Kaise leni hai)

Check the medicine name, strength and instructions before each course. Do not share a prescription or change its dose, duration or formulation without professional advice.

8. Timing (Kab leni chahiye)

Check the local leaflet or ask a pharmacist about food timing for this exact formulation; do not infer it from another medicine.

9. Missed Dose (Dose chhoot jaye)

Follow the exact leaflet or contact a pharmacist for missed-dose instructions. Do not double a dose or change a tapering or monitored treatment plan yourself.

10. Warnings (Ihtiyat)

• Low blood sugar can cause sweating, shaking or confusion. If awake and able to swallow, follow the advised fast-acting carbohydrate treatment.
• If unconscious, fitting or unable to swallow, do not give food or drink; call emergency services.
• Risk of prolonged low blood sugar is higher with missed meals and kidney or liver disease.
• A clinician should plan treatment before Ramadan fasting.
• Beta-blockers can mask some low-blood-sugar symptoms.

11. Precautions (Ahm ehtiyaat)

Check allergies, pregnancy or breastfeeding, kidney and liver conditions, and all other medicines with the prescriber or pharmacist. Store according to the local pack and keep out of reach of children. Below 25°C, protect from moisture

12. Side Effects (Nuksanat)

Reported effects

• Hypoglycaemia
• Weight gain
• Nausea
• Diarrhea
• Headache

Serious effects and warning symptoms

• Severe hypoglycaemia — unconsciousness, seizures (elderly, renal impairment, fasting)
• Haematological effects: thrombocytopenia, leukopenia (rare)
• Hepatotoxicity: jaundice, elevated liver enzymes (rare)

These lists do not establish the frequency of an effect or prove that a new symptom is caused by this medicine. Persistent or worsening symptoms need assessment.

13. Interactions (Dawaon ke sath reaction)

NSAIDs/aspirin (enhance hypoglycaemia); beta-blockers (mask symptoms); fluconazole/miconazole (enhance hypoglycaemia); alcohol (enhanced hypoglycaemia); rifampicin (reduces efficacy)

14. When to Get Help (Kab doctor se milein)

Seek emergency help for difficulty breathing, swelling of the face or throat, collapse, severe bleeding or suspected overdose. For the medicine-specific warning symptoms above, contact a clinician promptly. Bring the pack and a list of medicines.

15. Alternatives (Dusri dawaein)

Ask a pharmacist to compare the exact ingredients, strength, route and release type. A generic name alone does not prove dose equivalence. Do not substitute a combination product for a single-ingredient treatment.

16. Price in Pakistan (Price kitni hai)

A current price matched to the local strength and pack size has not been verified. Confirm the printed price, pack and expiry with a licensed pharmacy.

17. FAQs (Aksar poochay jane walay sawalat)

Q: Gliclazide Tablet kis kaam aati hai?

A: Gliclazide Tablet contains Gliclazide. Type 2 Diabetes Mellitus. The diagnosis and exact product determine suitability.

Q: Dose kaise confirm karein?

A: The dose depends on whether the tablet is standard-release (such as 80 mg) or modified-release (30 mg or 60 mg). Follow the exact formulation’s prescription; do not exchange strengths tablet-for-tablet.

Q: Bachon ke liye dose kya hai?

A: Not recommended in children — adult-onset Type 2 diabetes medicine

Q: Pakistan mein price kitni hai?

A: A current price matched to the local strength and pack size has not been verified. Confirm the printed price, pack and expiry with a licensed pharmacy.

Q: Nuksanat hon to kya karein?

A: Reported effects include Hypoglycaemia; Weight gain; Nausea. Seek medical help for Severe hypoglycaemia — unconsciousness, seizures (elderly, renal impairment, fasting); Haematological effects: thrombocytopenia, leukopenia (rare). A symptom list does not predict how often an effect occurs.

18. Editorial Information (Medical jaiza)

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: 2026-10-15

This correction adds ingredient-specific sources and separates verified facts from unverified local pack details. The recorded medical-review date is unchanged; this editorial correction is not a new clinician review. Foreign labels inform ingredient safety and do not establish Pakistani registration or every local pack’s instructions.

19. Disclaimer (Zaroori tanbeeh)

Educational information only. Confirm the diagnosis, local leaflet and individual prescription with a qualified clinician or pharmacist before starting, stopping or changing treatment.